A New VISTA in Intracellular Checkpoint Signaling in Triple-Negative Breast Cancer

Area of Science:

• Immunology
• Oncology
• Molecular Biology

Background:

• Immune checkpoint inhibitors (ICIs) have advanced cancer treatment, but resistance and limited efficacy in PD-L1-negative tumors necessitate novel therapeutic targets.
• V-domain immunoglobulin suppressor of T-cell activation (VISTA) is an emerging immune checkpoint target, but its precise signaling mechanisms in cancer remain elusive.
• Triple-negative breast cancer (TNBC) remains a challenge for ICI therapy, highlighting the need for understanding alternative tumor growth regulation mechanisms.

Purpose of the Study:

• To elucidate the mechanism by which VISTA regulates tumor growth in VISTA-expressing triple-negative breast cancers.
• To identify the functional domains and signaling pathways involved in VISTA-mediated tumor suppression.
• To explore the therapeutic potential of targeting VISTA's cell-intrinsic functions.

Main Methods:

• Analysis of VISTA expression and function in triple-negative breast cancer models.
• Identification of key amino acid motifs within VISTA's intracellular domain using mutational analysis.
• Investigation of VISTA's interaction with intracellular proteins, including adapter proteins and growth factor receptors, using co-immunoprecipitation and endosomal trafficking assays.
• Assessment of tumor growth inhibition and response to VISTA-blocking antibodies in preclinical models.

Main Results:

• VISTA suppresses tumor growth in a subset of triple-negative breast cancers through a cell-intrinsic, immune-independent mechanism.
• A conserved four-amino acid NPGF motif in VISTA's intracellular domain is essential for its antiproliferative activity.
• The NPGF motif mediates VISTA's function by sequestering the adapter protein NUMB at endosomes, thereby disrupting growth factor receptor trafficking and signaling.
• VISTA-expressing tumors demonstrate sensitivity to VISTA-blocking antibodies, contingent on the presence of the NPGF motif.

Conclusions:

• VISTA acts as a cell-intrinsic regulator of tumor growth, independent of its immune modulatory functions.
• The NPGF motif and its interaction with NUMB represent a novel mechanism of VISTA-mediated tumor suppression.
• Targeting VISTA's intracellular trafficking and signaling pathways offers a new therapeutic strategy for VISTA-expressing cancers, potentially overcoming resistance to conventional ICIs.